AXDX
Accelerate Diagnostics
AXDX
AXDX
Delisted
AXDX was delisted on the 14th of May, 2025.
99 hedge funds and large institutions have $205M invested in Accelerate Diagnostics in 2021 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 36 increasing their positions, 36 reducing their positions, and 17 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less call options, than puts
Call options by funds: $1.1M | Put options by funds: $2.22M
76% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 17
Holders
99
Holding in Top 10
3
Calls
$1.1M
Puts
$2.22M
Top Buyers
| 1 | +$4.91M | |
| 2 | +$2.35M | |
| 3 | +$698K | |
| 4 |
BlackRock
New York
|
+$551K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$510K |
Top Sellers
| 1 | -$10.9M | |
| 2 | -$8.09M | |
| 3 | -$3.98M | |
| 4 |
Two Sigma Investments
New York
|
-$1.35M |
| 5 |
OCMI
Oaktop Capital Management II
Chatham,
New Jersey
|
-$1.18M |